Medovate initiates scale-up with move to 6,000 sq ft Cambridge facility
Exactly two years since launch, Medovate, a Cambridge-based medical device development company, has signalled its next phase of growth with a relocation that will significantly increase its capacity.
Medovate will be moving from its 700 sq ft office in Milton Hall to new, state-of-the-art 6,000 sq ft offices on Camboro Business Park in Girton, Cambridge.
The expansion means that as the business continues to grow it will be well-placed to accommodate additional staff, providing a boost to local employment.
The relocation is in line with Medovate’s ambitious growth as it begins the commercialisation phase and launch of its innovative medical devices across the UK, Europe and the United States.
This will include SAFIRA (Safer Injection for Regional Anaesthesia), a revolutionary new technology to help prevent nerve damage during regional anaesthesia procedures, followed by Humidicare, a novel safety Heat and Moisture Exchanger (HME) to help prevent critical airway obstruction in intubated patients requiring ventilation.
Medovate’s new base will have the space needed to accommodate the growing team working on an exciting development pipeline of products and activities and will also include a training and development hub to support both commercial partners and distributors.
Managing director Stuart Thomson said: “This office relocation is the culmination of a great year for us; 2019 has seen the business go from strength to strength, with senior hires and receipt of an award naming us East of England’s most innovative medical device development company.
“As we approach 2020 there is more exciting news to come as we bring our innovative anaesthesia and critical care solutions to market. The new office will enable us to live up to our ambitious plans, providing increased levels of service for our customers as well as giving room for further expansion as the organisation continues to grow.”